Volume 45 Issue 2
Feb.  2024
Turn off MathJax
Article Contents
Ni GUO, Cheng ZHANG, Chao HONG, Weipeng LIU, Yufeng YAO, Zhiling YAN. Correlation of KRAS Gene 3′ UTR Polymorphisms with Cervical Cancer and Cervical Intraepithelial Neoplasia in Chinese Han Population in Yunnan Province[J]. Journal of Kunming Medical University, 2024, 45(2): 14-22. doi: 10.12259/j.issn.2095-610X.S20240203
Citation: Ni GUO, Cheng ZHANG, Chao HONG, Weipeng LIU, Yufeng YAO, Zhiling YAN. Correlation of KRAS Gene 3′ UTR Polymorphisms with Cervical Cancer and Cervical Intraepithelial Neoplasia in Chinese Han Population in Yunnan Province[J]. Journal of Kunming Medical University, 2024, 45(2): 14-22. doi: 10.12259/j.issn.2095-610X.S20240203

Correlation of KRAS Gene 3′ UTR Polymorphisms with Cervical Cancer and Cervical Intraepithelial Neoplasia in Chinese Han Population in Yunnan Province

doi: 10.12259/j.issn.2095-610X.S20240203
  • Received Date: 2024-01-16
    Available Online: 2024-02-27
  • Publish Date: 2024-02-25
  •   Objective  To investigate the correlation between rs712 and rs7973450 located at the 3′ UTR region of the KRAS gene and the risk of cervical cancer (CC) and cervical intraepithelial neoplasia (CIN) in Chinese Han population in Yunnan province.   Methods  A total of 2405 individuals (461 subjects with CIN, 961 subjects with CC and 983 healthy controls) were enrolled. The SNPs were genotyped used TaqMan assay and the correlation of these SNPs with CIN and CC was analyzed.   Results  The A allele of rs7973450 might be a protective factor for the occurrence of CIN (P = 0.004, OR= 0.651, 95%CI 0.487 ~ 0.871) and CC (P = 7.00 × 10-4, OR= 0.667, 95%CI 0.529 ~ 0.844). There was no significant difference in allelic and genotypic distribution of rs712 among CIN, CC and Control groups (P > 0.017). The haplotype assay showed thatrs712A-rs7973450G was associated with increased risk of CIN (P = 4.00 × 10-4; OR= 1.714, 95%CI 1.269 ~ 2.314) and CC (P = 3.84 × 10-5, OR= 1.667, 95%CI 1.305 ~ 2.131). While haplotype rs712A-rs7973450A was associated with a lower risk of CC (P = 0.012, OR= 0.790, 95%CI 0.658 ~ 0.950).   Conclusion  The A allele of rs7973450 in 3′ UTR of KRAS gene might be the protective factor for the occurrence of CIN and CC in a Chinese Han population in Yunnan province.
  • loading
  • [1]
    Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. doi: 10.3322/caac.21660
    [2]
    Zheng R,Zhang S,Zeng H,et al. Cancer incidence and mortality in China,2016[J]. Journal of the National Cancer Center,2022,2(1):1-9. doi: 10.1016/j.jncc.2022.02.002
    [3]
    Crosbie E J,Einstein M H,Franceschi S,et al. Human papillomavirus and cervical cancer[J]. Lancet,2013,382(9895):889-899. doi: 10.1016/S0140-6736(13)60022-7
    [4]
    Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nature reviews Cancer,2002,2(5):342-350. doi: 10.1038/nrc798
    [5]
    Bowden S J,Bodinier B,Kalliala I,et al. Genetic variation in cervical preinvasive and invasive disease: A genome-wide association study[J]. Lancet Oncol,2021,22(4):548-557. doi: 10.1016/S1470-2045(21)00028-0
    [6]
    Chen B,Yi C,Wang J,et al. A comprehensive study of CD44 rs 187115 variant and cancer risk in a central Chinese population[J]. J Cell Biochem,2019,120(8):12949-12957. doi: 10.1002/jcb.28566
    [7]
    Wang F,Shan S,Huo Y,et al. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer[J]. Int J Biochem Cell Biol,2018,99:91-99. doi: 10.1016/j.biocel.2018.04.005
    [8]
    Huang L,Guo Z,Wang F,et al. KRAS mutation: from undruggable to druggable in cancer[J]. Signal Transduct Target Ther,2021,6(1):386. doi: 10.1038/s41392-021-00780-4
    [9]
    Wang D, Liu Q, Ren Y, et al. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival [J]. Biosci Rep, 2021, 41(4): BSR20204136.
    [10]
    Paranjape T,Heneghan H,Lindner R,et al. A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis[J]. Lancet Oncol,2011,12(4):377-386. doi: 10.1016/S1470-2045(11)70044-4
    [11]
    Li Z H,Pan X M,Han B W,et al. A let-7 binding site polymorphism rs712 in the KRAS 3′ UTR is associated with an increased risk of gastric cancer[J]. Tumour Biol,2013,34(5):3159-3163. doi: 10.1007/s13277-013-0885-x
    [12]
    Hussen B M,Hidayat H J,Salihi A,et al. MicroRNA: A signature for cancer progression[J]. Biomed Pharmacother,2021,138:111528. doi: 10.1016/j.biopha.2021.111528
    [13]
    Kim M,Slack F J. MicroRNA-mediated regulation of KRAS in cancer[J]. J Hematol Oncol,2014,7:84. doi: 10.1186/s13045-014-0084-2
    [14]
    国家癌症中心,国家肿瘤质控中心宫颈癌质控专家委员会. 中国宫颈癌规范诊疗质量控制指标(2022版)[J]. 中华肿瘤杂志,2022,44(7):615-22.
    [15]
    Bhatla N,Aoki D,Sharma D N,et al. Cancer of the cervix uteri[J]. Int J Gynaecol Obstet,2018,143(S2):22-36.
    [16]
    WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [M]. 2nd ed. Geneva: World Health Organization, 2021.
    [17]
    Simanshu D K,Nissley D V,Mccormick F. RAS Proteins and Their Regulators in Human Disease[J]. Cell,2017,170(1):17-33. doi: 10.1016/j.cell.2017.06.009
    [18]
    Zhu G,Pei L,Xia H,et al. Role of oncogenic KRAS in the prognosis,diagnosis and treatment of colorectal cancer[J]. Molecular Cancer,2021,20(1):143. doi: 10.1186/s12943-021-01441-4
    [19]
    Li Z,Chen Y,Wang D,et al. Detection of KRAS mutations and their associations with clinicopathological features and survival in Chinese colorectal cancer patients[J]. J Int Med Res,2012,40(4):1589-1598. doi: 10.1177/147323001204000439
    [20]
    Fernández-Medarde A,Santos E. Ras in cancer and developmental diseases[J]. Genes Cancer,2011,2(3):344-358. doi: 10.1177/1947601911411084
    [21]
    Hu H, Cheng R, Wang Y, et al. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47 [J]. J Clin Invest, 2023, 133(2): e153470.
    [22]
    Kumar M S,Swanton C. KRAS 3′-UTR variants and stratification of breast-cancer risk[J]. Lancet Oncol,2011,12(4):318-319. doi: 10.1016/S1470-2045(11)70065-1
    [23]
    Nelson H H,Christensen B C,Plaza S L,et al. KRAS mutation,KRAS-LCS6 polymorphism,and non-small cell lung cancer[J]. Lung Cancer,2010,69(1):51-3. doi: 10.1016/j.lungcan.2009.09.008
    [24]
    Ibrahim H, Lim Y C. KRAS -associated microRNAs in colorectal cancer[J] 2020, 14(2): 454.
    [25]
    Liu H,Huang J,Peng J,et al. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway[J]. Mol Cancer,2015,14:59.
    [26]
    Johnson S M,Grosshans H,Shingara J,et al. RAS is regulated by the let-7 microRNA family[J]. Cell,2005,120(5):635-647. doi: 10.1016/j.cell.2005.01.014
    [27]
    Ahmed E A, Rajendran P, Scherthan H. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor [J]. Int J Mol Sci, 2022, 23(11): 5870.
    [28]
    Gallegos-Arreola M P,Z ú ñiga-Gonz á lez G M,Gómez-Mariscal K,et al. Association of rs712 polymorphism in a let-7 microRNA-binding site of KRAS gene with colorectal cancer in a Mexican population[J]. Iran J Basic Med Sci,2019,22(3):324-327.
    [29]
    Jiang Q H,Peng H X,Zhang Y,et al. rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population[J]. OncoTargets and Therapy,2015,8:3041-3045.
    [30]
    Huang X,Yang Y,Guo Y,et al. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer[J]. Genet Mol Res,2015,14(4):16913-16920. doi: 10.4238/2015.December.14.19
    [31]
    Chin L J,Ratner E,Leng S,et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non–small cell lung cancer risk[J]. Cancer Research,2008,68(20):8535-8540. doi: 10.1158/0008-5472.CAN-08-2129
    [32]
    Fu W,Zhuo Z,Hua R X,et al. Association of KRAS and NRAS gene polymorphisms with Wilms tumor risk: A four-center case-control study[J]. Aging (Albany NY),2019,11(5):1551-1563. doi: 10.18632/aging.101855
    [33]
    Guan Q,Yuan L,Lin A,et al. KRAS gene polymorphisms are associated with the risk of glioma: A two-center case-control study[J]. Transl Pediatr,2021,10(3):579-586. doi: 10.21037/tp-20-359
    [34]
    Lin A,Hua R X,Tang J,et al. KRAS rs7973450 A>G increases neuroblastoma risk in Chinese children: A four-center case-control study[J]. Onco Targets Ther,2019,12:7289-7295. doi: 10.2147/OTT.S223220
    [35]
    Insodaite R,Smalinskiene A,Liutkevicius V,et al. Associations of Polymorphisms Localized in the 3′ UTR Regions of the KRAS,NRAS,MAPK1 genes with laryngeal squamous cell carcinoma[J]. Genes,2021,12(11):1679. doi: 10.3390/genes12111679
  • Relative Articles

    [1] Hong PAN, Duwei DENG, Shilin LIU. The Diagnostic Analysis of Adler Grade of Color Ultrasound for Cervical Cancer and Its Correlation with Pathological Index. Journal of Kunming Medical University, 2024, 45(5): 109-115.  doi: 10.12259/j.issn.2095-610X.S20240517
    [2] Xueya CHEN, Jinmei XU, Zhi LI, Yan LIANG, Yufeng YAO, Fengquan HE, Zhiling YAN. The Association of HOXD-AS2 and MIR3142HG Gene Polymorphisms with Cervical Intraepithelial Neoplasia. Journal of Kunming Medical University, 2024, 45(11): 16-21.  doi: 10.12259/j.issn.2095-610X.S20241103
    [3] Yuhan SHI, Jianghong CHAI, Jinmei XU, Mu LIN, Yufeng YAO, Fengquan HE, Zhiling YAN. The Association between miR-146a Gene Polymorphism and Cervical Intraepithelial Neoplasia. Journal of Kunming Medical University, 2024, 46(): 1-7.
    [4] Zhixin NIU, Lihua TANG, Lei SHI, Chao HONG, Yufeng YAO, Zhiling YAN. Correlation of MAPK1 and NRAS Gene Polymorphisms with Cervical Intraepithelial Neoplasia in Yunnan Han Population. Journal of Kunming Medical University, 2024, 45(5): 8-15.  doi: 10.12259/j.issn.2095-610X.S20240502
    [5] Shujin LI, Yanfei YANG, Min SU, Yu LING, Yanqiong RAO, Jihua CUI. Single Nucleotide Polymorphisms in Children with Attention Deficit Hyperactivity Disorder Comorbid Emotion Problems. Journal of Kunming Medical University, 2023, 44(4): 139-147.  doi: 10.12259/j.issn.2095-610X.S20230420
    [6] Rongshuang WU, Jiangli PENG, Yonggang CHEN, Jie CHEN, Guowei MA, Xianrui LI, Xie LI, Chunhong YU. Associations between SLC2A9 Single Nucleotide Polymorphisms and Susceptibility to Pyrazinamide Induced Hyperuricemia. Journal of Kunming Medical University, 2023, 44(4): 40-47.  doi: 10.12259/j.issn.2095-610X.S20230409
    [7] Dong-yun LI, Shun-kui GANG, Jie LI, Ming-xing ZHANG, Lei LI. Association of ABCG2,SLC2A9,SLC17A3 and PRKG2 SNPs Variants with Gout in the Hani Population in China. Journal of Kunming Medical University, 2021, 42(3): 54-60.  doi: 10.12259/j.issn.2095-610X.S20210320
    [8] Ding-ji TAN, Hong-li YIN, Rui ZHU, Xi ZHANG, Xin YU, Yong FEI, Xin LI, Ming DUAN, Liang HE, Hong-ying YANG. Analysis of Vaginal Microecological in Women with Cervical Intraepithelial Neoplasia and Cervical Cancer. Journal of Kunming Medical University, 2021, 42(8): 118-122.  doi: 10.12259/j.issn.2095-610X.S20210821
    [9] Liu Yang , Huang Ya Juan , Liao Jing , Sun Chun Yi , Di Shu Juan , Zhou Hong Lin . . Journal of Kunming Medical University, 2019, 40(12): 69-72.
    [10] Di Shu Juan , Pan Jing , Sun Chun Yi , Liu Yang , Yang Ying Ying , Zhou Hong Lin . . Journal of Kunming Medical University, 2019, 40(04): 82-85.
    [11] Li Die Mei . The Clinical Value of Loop Electrosurgical Excision Procedure in Treating Cervical Intraepithelial Neoplasia. Journal of Kunming Medical University,
    [12] Liu Cheng Xiu . Association Study of TNF-α and ALCAM Polymorphisms with Chronic HCV Infection in Yunnan Han Population. Journal of Kunming Medical University,
    [13] Zhu Sheng Zhang . Clinical Analysis of Liquid-based Cervical Cytology Examination in Cervical Cancer Screening in the South of GuiZhou. Journal of Kunming Medical University,
    [14] Xiang Xi . The Correlation between Vitamin D Receptor Gene FokI Single Nucleotide Polymorphism and Diabetic Kidney Disease. Journal of Kunming Medical University,
    [15] Liu Li Li . . Journal of Kunming Medical University,
    [16] Dai Shu Ying . . Journal of Kunming Medical University,
    [17] Li Ying . . Journal of Kunming Medical University,
    [18] Yan Zhi Ling . . Journal of Kunming Medical University,
    [19] Yang Xiao Lei . . Journal of Kunming Medical University,
    [20] Huang Ya . . Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(8)

    Article Metrics

    Article views (1079) PDF downloads(21) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return